L. Steinbusch

Stress sensitivity of childhood epilepsy is related to experienced negative life events

Jolien S. van Campen, Floor E. Jansen, L. Steinbusch et al. · Epilepsia · 2012 · 38 citations

Medicine, Child Health, Pediatrics +14

Safety, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of AZD2936, a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-experienced advanced/metastatic non-small-cell lung cancer (NSCLC): First report of ARTEMIDE-01.

Kristoffer Staal Rohrberg, Mariana Brandão, Eduardo Castañón Álvarez et al. · Journal of Clinical Oncology · 2023 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

79MO PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

Fiona McDonald, F. Mornex, Marina Chiara Garassino et al. · Journal of Thoracic Oncology · 2021 · 13 citations · Full text

Medicine, Oncology, Chemotherapy +7

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study

Mitchell Emmers, Marij J.P. Welters, Michelle V. Dietz et al. · Nature Communications · 2025 · 12 citations · Full text

Life Sciences, Immunology, Oncology +17

1446P Preliminary efficacy and safety of rilvegostomig (AZD2936), a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-pretreated advanced/metastatic non-small-cell lung cancer (NSCLC): ARTEMIDE-01

Mariana Brandão, J.T.J.N. Hiltermann, Els Wauters et al. · Annals of Oncology · 2023 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17